U.S. pharmaceutical stocks are approaching all-time highs. AbbVie, Eli Lilly and Gilead Sciences are trading at or near record levels. This trend is driven by investors rotating out of the tech sector toward safer assets. Equity markets as a whole are experiencing volatility amid this sector rebalancing.
Source: Read the original article
Disclaimer: this content is for information purposes only and is not financial advice. Cryptocurrencies are highly volatile: you may lose all of your capital. Always do your own research. Legal notice
